MBIO: Mustang Bio, Inc. Stock

by  •  • Comments Off on MBIO: Mustang Bio, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 100.39
Enterprise Value ($M) 96.87
Book Value ($M) -8.66
Book Value / Share -6.68
Price / Book -11.60
NCAV ($M) -9.79
NCAV / Share -7.56
Price / NCAV -10.25

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -1.32
Return on Equity (ROE) -190.37

Liquidity (mrq)
Quick Ratio 0.40
Current Ratio 0.40

Balance Sheet (mrq) ($M)
Current Assets 6.05
Assets 7.19
Liabilities 15.85
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Armistice Capital, Llc
01-03 13D/A Fortress Biotech, Inc. 12.40 160.73

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 32,368 87,076 37.17
2025-03-06 28,625 125,871 22.74
2025-03-05 9,307 83,411 11.16
2025-03-04 61,366 253,717 24.19

(click for more detail)

Similar Companies
LQDA – Liquidia Corporation LSTA – Lisata Therapeutics, Inc.
LTRN – Lantern Pharma Inc. MBRX – Moleculin Biotech, Inc.
ME – 23andMe Holding Co.


Financial data and stock pages provided by
Fintel.io